Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Panpharma Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (9)
ARTG (2)
Prescription medicine registration (2)

Date

2026 (5)
2022 (2)
2021 (2)
2019 (2)
2018 (2)

Search

Sponsor content

13 result(s) found, displaying 11 to 13

CASPOFUNGIN PANPHARMA INJECTION caspofungin (as acetate) 50 mg powder for injection vial Cancelled under Section 30(1)(c) of the Act

24 June 2019

Cancellation by sponsor

Requested by Panpharma Australia Pty Ltd
CASPOFUNGIN PANPHARMA INJECTION caspofungin (as acetate) 70 mg powder for injection vial Cancelled under Section 30(1)(c) of the Act

24 June 2019

Cancellation by sponsor

Requested by Panpharma Australia Pty Ltd
ERYTHROMYCIN PANPHARMA (Panpharma Australia Pty Ltd)

24 September 2018

Prescription medicine registration

Active ingredients: Erythromycin lactobionate.

Pages

First page
Previous page
Page 1
Current page 2

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.

Product regulation

Safety and shortages

Resources and guidance

Business services

Panpharma Australia Pty Ltd

Type

Date

CASPOFUNGIN PANPHARMA INJECTION caspofungin (as acetate) 50 mg powder for injection vial Cancelled under Section 30(1)(c) of the Act

CASPOFUNGIN PANPHARMA INJECTION caspofungin (as acetate) 70 mg powder for injection vial Cancelled under Section 30(1)(c) of the Act

ERYTHROMYCIN PANPHARMA (Panpharma Australia Pty Ltd)